U.S. and Iran trade fire in Strait of Hormuz; each claims other shot first

5 hours ago

Iran focus at Trump-Xi summit may delay progress on tariffs, rare earths

2 hours ago

Cloudflare stock sinks 18% after earnings as company cuts 1,100 employees due to AI changes

5 hours ago

France is fan favorite for the FIFA World Cup — but AI is backing another nation for glory, says BofA

12 hours ago

Shell CEO says oil market is short nearly 1 billion barrels due to Iran war, and the hole deepens every day

6 hours ago

Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk

9 hours ago

Planet Fitness stock plunges 30% after company slashes guidance

9 hours ago

Family office deal-making rebounds in April with healthcare bets

15 hours ago

Rare disease families find roadmap to drug development at bootcamps

16 hours ago

Novo Nordisk CEO says the drugmaker is more active than ever for dealmaking

16 hours ago

Wearable patches: How Barrière is trying to disrupt the supplement industry

1 day ago

CVS blows past estimates, hikes outlook as insurance business outperforms

1 day ago

FDA withdrew studies finding Covid and shingles vaccines were safe

1 day ago

FDA commissioner defends agency's drug approval decisions after wave of backlash

2 days ago

Major health insurers show early strength – but a key test looms in Q2

2 days ago

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

2 days ago

Novo's head start on GLP-1 pills forces investors to rethink Lilly's dominance

2 days ago

Weight loss and hair loss: The growing hair treatment market from GLP-1s

5 days ago

Cardinal Health's sell-off on earnings was an overreaction. We'd be buyers

6 days ago

Trump picks Nicole Saphier for surgeon general after pulling Casey Means

6 days ago

Eli Lilly shares surge on a beat-and-raise, proving the stock's swoon was a mistake

7 days ago

FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list

7 days ago

More than 20,000 people are taking Eli Lilly's weight loss pill Foundayo, CEO says

7 days ago

Merck beats quarterly estimates on strength of Keytruda, narrows outlook

7 days ago

Eli Lilly blows past quarterly estimates, hikes outlook

7 days ago

Novartis CEO warns reality of Trump's drug pricing policy will set in over 'the next 18 months'

9 days ago

Pharma bets on a little-known cholesterol for its next blockbuster heart drugs

9 days ago

Spotify teams up with Peloton to launch global fitness content hub

10 days ago

Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

10 days ago

Regeneron weighs overseas price for gene therapy for rare type of hearing loss

10 days ago

FDA fast-tracks psychedelic drug research following Trump executive order

13 days ago

Cramer says look to these 4 stocks to go with your high-flying tech names

14 days ago

Regeneron inks drug pricing deal with Trump, will offer hearing-loss therapy for free

14 days ago

Trump admin moves to reclassify cannabis in shift that could expand research

14 days ago

RFK Jr. says he would support a potential ban on junk food TV ads

15 days ago

Amazon launches GLP-1 weight loss program, promising 'fast, convenient' access

16 days ago

UnitedHealth Group tops quarterly estimates, hikes profit outlook

16 days ago